Acura Pharmaceuticals Inc (ACUR)

OTC Markets
0.600
+0.025(+4.35%)
  • Volume:
    1,050
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.600 - 0.600

ACUR Overview

Prev. Close
0.575
Day's Range
0.6-0.6
Revenue
3.12M
Open
0.6
52 wk Range
0.15-0.754
EPS
-0.02
Volume
1,050
Market Cap
39.05M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
14,261
P/E Ratio
-
Beta
0.69
1-Year Change
119.78%
Shares Outstanding
65,089,043
Next Earnings Date
Aug 18, 2021
What is your sentiment on Acura Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Acura Pharmaceuticals Inc News

Acura Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralNeutralBuy
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellSellNeutralStrong Buy

Acura Pharmaceuticals Inc Company Profile

Acura Pharmaceuticals Inc Company Profile

Employees
0

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

Read More
  • eh
    0
    • Where's my money did I lose it all I iddnt sell
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.